THE GLOBAL E-PRESCRIBING MARKET SIZE TO CROSS USD 3 BILLION IN 2026, GROWING AT A CAGR OF OVER 21% DURING 2021-2026

E-prescribing Market Size, Share, Trends Analysis Report by Type (Standard E-prescribing and Electronic Prescribing for Controlled Substances), Delivery Mode (Web & Cloud-based and On-premise & Desktop), Modality (Integrated and Standalone), Medication Type (Cardiovascular, Anti-infectives, Oncology, Pain Medication, Behavioral & Mental Health, Others), End-user (Technology Vendors, Independent & Specialty Pharmacies, Healthcare Facilities, Pharmacy Benefit Management (PBM) & Payors), and Geography (North America, Europe, APAC, Latin America, and the Middle East & Africa); Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021–2026

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

361 Pages

icon-table

169 Tables

icon-chart

173 Charts

icon-region

5 Regions

icon-country

16 Countries

icon-company

20 Companies

icon-market

6 Market Segment

GLOBAL E-PRESCRIBING MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 3 BILLION (2026)
CAGR 21% (2021–2026)
Base Year 2020
Forecast Year 2021-2026
Market Segments Type (Standard E-Prescribing, Electronic Prescribing for Controlled Substances (EPCS)); Delivery Mode (Web-Based, Cloud-Based, and On-Premise or Desktop-Based); Modality (Integrated and Standalone); Medication (Cardiovascular, Oncology, Anti-infective, Behavioral & Mental Health, Pain Medication and Others); End-User (Healthcare Facilities, Technology Vendors, Independent & Specialty Pharmacies, and PBM & Payors)
Geographic Analysis North America, Europe, APAC, Latin America, and the Middle East & Africa
Countries Covered US, Canada, UK, Italy, Spain, China, India, Japan, South Korea, Australia, Mexico, Brazil, Saudi Arabia, Turkey, South Africa

E-PRESCRIBING INDUSTRY INSIGHTS

The global e-prescribing market size was valued at USD 960 million in 2020 and is expected to reach USD 3 billion in 2026, growing at a CAGR of 21% during the forecast period.

There has been steady growth in the adoption of national electronic health records (EHR) systems and witnessed a 46% increase in implementation over the past five years. With the introduction of e-prescribing solutions, its integration with EHRs has highly increased. The advanced features such as clinical decision support, patient management systems, electronic prior authorization, and many others are accelerating the demand for e-prescribing solutions. In 2020, the standard eprescribing market accounted for the largest share of 92.52%. The web and cloud-based segment is likely to witness the highest incremental growth of USD 1,668.74 and absolute growth of 226.17% during the forecast period. North America dominated the global e-prescribing market followed by Europe.

Surescripts’ e-prescribing platform hit the 1 million prescriber mark during the spread of COVID-19. The pandemic has generated a shift toward telehealth as part of the solution for breaking community transmission. Outpatient visits dropped roughly 60% during March 2019, which boosted telehealth visits up to 46% across health facilities. With the decrease in ambulatory care visits and an increase in telehealth or remote visits, health organizations and clinicians have leveraged health IT and electronic health records (EHR) to provide optimal patient care.

E-PRESCRIBING MARKET GROWTH ENABLERS

  • In the US, the federal government has played a significant role in encouraging the use of e-prescribing technology and stimulating associated research nationwide. The federal government has also increased e-prescribing research initiatives through agencies such as the Agency for Healthcare Research and Quality (AHRQ) and the Health Resources and Services Administration (HRSA).
  • The development of indication e-prescribing allows clear assessments of drug effectivity to support the research of drug outcomes and make prompt changes in labeling or prescribing drugs for off-label use. The Agency for Healthcare Research and Quality (AHRQ) has funded a three-year project to create and test a prototype system.
  • Digital transformation in healthcare and electronic prescribing services has become significant and critical to offer quality patient care. Quality and optimization of e-prescribing are key focus areas for digital transformation. For instance, Surescripts has offered information regarding quality-related transactions, such as the Structured and Codified Sig.

E-PRESCRIBING MARKET SEGMENTATION

This research report includes a detailed segmentation by

  • Type
  • Delivery Mode
  • Modality
  • Medication Type
  • End-user
  • Geography

Standard solutions are likely to grow at a CAGR of over 21% during 2020–2026 due to the high prevalence of prescription errors in health centers.

In 2020, standard e-prescribing solutions accounted for a significant share of over 92%, and they expect to observe an incremental growth of over USD 1.9 million during the forecast period. The modern e-prescribing system is a robust technology that facilitates an interactive data transaction. Transactions in the e-prescribing software allow prescribers to view the complete profile of the patients’ medication. The software increases the effectiveness and efficiency of patient care through automated clinical decision support and tracking complete medication profiles. Electronic prescribing for controlled substances (EPCS) is likely to grow, with the highest CAGR of over 23% during the forecast period. EPCS technology help to streamline the prescriber’s workflow, improve medication safety, and reduce drug diversions and frauds. In the US, 28 states have already mandated the use of EPCS.

Web & Cloud-based solutions expect to account for approx. USD 2.4 billion by 2026 due to the demand for effective and efficient health services.

In terms of delivery, web and cloud-based software held a major share of over 76% in 2020. The segment is likely to witness the highest incremental growth of over USD 1.6 billion during the forecast period. Web and cloud-based solutions are utilized by many healthcare settings such as hospitals, pharmacies, and ambulatory centers; hence, their demand is high during the forecast period. The global on-premise & desktop e-prescribing market is likely to reach over USD 645 million by 2026, growing at a CAGR of over 19%. On-premises solutions are less advanced than web and cloud-based solutions and lack the capabilities to stay current with security, performance, and reliability. However, on-premise software resides within the organization’s premises and offers higher security, protection, and control than cloud computing infrastructure.  

Integrated solutions are likely to observe an incremental growth of USD 1.9 billion by 2026 due to an increased focus on security, patient privacy, and the prevention of fraudulent medical activities.

Integrated e-prescribing solutions are in high demand, accounting for a major share of 87% of the segment. Eprescribing software integrated with EHR is highly preferred compared to standalone systems. Integrated software is likely to witness the highest absolute growth of approx. 225% and growing with a CAGR of over 21% during the forecast period. Vendors are increasingly focusing on integrating EHR into e-prescribing solutions. Standalone accounted for over 13% of the global e-prescribing market share in 2020. Standalone e-prescribe systems are economical than integrated solutions. It is considered an efficient way to transit to electronic data and workflow management or telehealth capabilities.

Cardiovascular solutions are likely to grow at a CAGR of over 20% during 2020–2026 because of the increasing prevalence of cardiovascular diseases.

Cardiovascular drugs are the most commonly e-prescribed medications due to the increasing prevalence of heart disorders. With the increased utilization of cardiovascular drugs, e-prescribing has highly increased. EHRs that are used for e-prescribing cardiovascular drugs are also increasingly adopted by prescribers. Several companies have developed cardiology-based EHR software solutions, which are highly utilized for eprescribing and integrated with EHR systems.

Healthcare facilities are likely to adopt at a favorable rate of 25% during 2020–2026 due to the inherent complexity of the medication process and contextual factors.

Technology vendors, independent and specialty pharmacies, healthcare facilities, and pharmacy benefits management and payors are the major end-users of the e-prescribing market. Technology vendors accounted for the highest share of over 73% and will witness an incremental growth of USD 1.4 billion during the forecast period. E-prescribing is rapidly growing in the telehealth field due to its substantial benefits for office-based physicians’ workflow and patient safety. Vendors are customizing their telehealth services by including electronic prescribing. Electronic prescriptions integrated with advanced telehealth solutions can be used for routine check-ups or prescription refills.

SEGMENTATION BY GEOGRAPHY

Europe is likely to grow at the highest CAGR of over 23% during the forecast period due to high medication errors and increased opioid-related mortalities.

The North American e-prescribing market expects to reach over USD 1.2 billion by 2026, growing at a CAGR of over 20% during the forecast period. Major factors contributing to the largest share include the growing focus on decreasing prescription errors, reduce controlled substance abuse, increasing adoption of EHR solutions, government incentives, and initiatives for implementing e-prescribing across healthcare settings. Advances in software and increased digitalization in healthcare IT infrastructure contribute to the high adoption of e-prescribing in the region. Rising concerns over prescription errors resulting in drug overdose deaths are driving the demand for U.S. E-prescribing market growth. The Europe e-prescribing market is expected to grow at a CAGR of around 23% during the forecast period.

COMPETITIVE LANDSCAPE

The global e-prescribing market is likely to witness the entry of new players and increased collaboration with major software vendors. The prominent players in the market are Surescripts, DrFirst, Practice Fusion, and Insync Healthcare Solutions. Several key players are integrating eprescribing services with EHR software to increase product differentiation among end-users. They focus on providing integrated services, which contributes to the market share. Primary healthcare settings utilize integrated services, and standalone has become limited to private clinics or small healthcare facilities.  

The global e-prescribing market research report includes in-depth coverage of the industry analysis with revenue, market trends, and forecast insights for the following segments:

Type

  • Standard E-prescribing
  • Electronic Prescribing for Controlled Substances

Delivery Mode

  • Web & Cloud-based
  • On-premise & Desktop

Modality

  • Integrated
  • Standalone

Medication Type

  • Cardiovascular
  • Anti-infectives
  • Oncology
  • Pain Medication
  • Behavioral & Mental Health
  • Others

End-user

  • Technology Vendors
  • Independent & Specialty Pharmacies
  • Healthcare Facilities
  • Pharmacy Benefit Management (PBM) & Payors

Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • South Africa

Frequently Asked Questions

How big is the global e-prescribing market?

The global e-prescribing market expects to reach over USD 3 billion by 2026.

What is the e-prescribing market growth?

The global e-prescribing market is likely to grow at a CAGR of over 21% during 2020–2026.

Which segment accounted for the largest e prescribing market share?

In terms of modality, the integrated segment expects to reach over USD 2.7 billion by 2026.

What are the key driving factors for the e-prescribing market?

Increased demand for electronic health record services and Government initiatives and incentive programs are the major factors responsible for the growth of e-prescribing solutions.

Who are the leading players in the e-prescribing market?

Surescripts, DrFirst, Practice Fusion, and InSync Healthcare Solutions are the leading players in the global e-prescribing market.

What is the top e-prescribing industry trend in the United States?

The need to reduce prescription errors and reduce opioid consumption are the major trends observed in the US e-prescribing industry.

Download Free Sample

The global e-prescribing market by revenue is expected to grow at a CAGR of over 21% during the period 2020–2026.

The following factors are likely to contribute to the growth of the e-prescribing market during the forecast period:

  • Development of Indication-based Prescribing Systems
  • Outsourcing of E-prescribing Software & Development of E-prescribing Applications
  • Advances in E-prescribing Solutions
  • Increased Demand for Electronic Health Record Services

Base Year:                  2020

Forecast Year:           2021–2026

The study considers the global e-prescribing market’s present scenario and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Prominent Vendors

  • Surescripts
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • DrFirst
  • Practice Fusion
  • InSync Healthcare Solutions

Other Prominent Vendors

  • eRx Network
    • Business Overview
    • Product Offerings
  • Henry Schein
  • AdvancedMD
  • MD Toolbox
  • Bravado Health
  • RXNT
  • Daw Systems
  • DoseSpot
  • Chetu Inc.
  • Aegis Healthcare
  • SISGAIN
  • Credible
  • Streamline Healthcare Solutions
  • Canada Health Infoway
  • DrChrono
  • Bizmatics

Type

  • Standard E-prescribing
  • Electronic Prescribing for Controlled Substances

Delivery Mode

  • Web & Cloud-based
  • On-premise & Desktop

Modality

  • Integrated
  • Standalone

Medication Type

  • Cardiovascular
  • Anti-infectives
  • Oncology
  • Pain Medication
  • Behavioral & Mental Health
  • Others

End-user

  • Technology Vendors
  • Independent & Specialty Pharmacies
  • Healthcare Facilities
  • Pharmacy Benefit Management (PBM) & Payors

Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • South Africa

1            Research Methodology

2            Research Objectives

3            Research Process

 

4            Scope & Coverage

4.1        Market Definition

4.1.1     Inclusions

4.1.2     Exclusions

4.2        Base Year

4.3        Scope Of The Study

4.3.1     Market Segmentation by Type

4.3.2     Market Segmentation by Delivery Mode

4.3.3     Market Segmentation by Modality

4.3.4     Market Segmentation by Medication Type

4.3.5     Market Segmentation by End User

4.3.6     Market Segmentation by Geography

 

5            Report Assumptions & Caveats

5.1        Key Caveats

5.2        Currency Conversion

5.3        Market Derivation

 

6            Market At A Glance

7            Introduction

7.1        Overview

7.1.1     Features of an Ideal Electronic Prescribing System

7.1.2     Standards for Electronic Prescription Systems

 

8            Market Opportunities & Trends

8.1        Development Of Indication-Based E-Prescribing Systems

8.2        Outsourcing E-Prescribing Software Development

8.3        Advancements In E-Prescribing Solutions

 

9            Market Growth Enablers

9.1        Increased Demand For EHR Services

9.2        Government Initiatives & Incentive Programs

9.3        Prescription Error Prevention & Clinical Decision Support Automation

9.4        Increasing Focus To Reduce & Monitor Controlled Substances

 

10         Market Restraints

10.1      E-Prescribing & E-Formulary Errors

10.2      High Cost of Deployment & Security Concerns

10.3      Complex Technology & Software Designing Issues

 

11         Market Landscape

11.1      Market Overview

11.2      Market Size & Forecast

11.3      Impact Of COVID-19

11.4      Five Forces Analysis

11.4.1   Threat of New Entrants

11.4.2   Bargaining Power of Suppliers

11.4.3   Bargaining Power of Buyers

11.4.4   Threat of Substitutes

11.4.5   Competitive Rivalry

 

12         Type

12.1      Market Snapshot & Growth Engine

12.2      Market Overview

12.3      Standard E-Prescribing

12.3.1   Market Overview

12.3.2   Market Size & Forecast

12.3.3   Standard E-prescribing: Geography Segmentation

12.4      EPCS

12.4.1   Market Overview

12.4.2   Market Size & Forecast

12.4.3   EPCS: Geography Segmentation

 

13         Delivery Mode

13.1      Market Snapshot & Growth Engine

13.2      Market Overview

13.3      Web & Cloud-Based

13.3.1   Market Overview

13.3.2   Market Size & Forecast

13.3.3   Web & Cloud-Based: Geography Segmentation

13.4      On-Premises & Desktop

13.4.1   Market Overview

13.4.2   Market Size & Forecast

13.4.3   On-Premises & Desktop: Geography Segmentation

 

14         Modality

14.1      Market Snapshot & Growth Engine

14.2      Market Overview

14.3      Integrated

14.3.1   Market Overview

14.3.2   Market Size & Forecast

14.3.3   Integrated: Geography Segmentation

14.4      Standalone

14.4.1   Market Overview

14.4.2   Market Size & Forecast

14.4.3   Standalone: Geography Segmentation

 

15         Medication Type

15.1      Market Snapshot & Growth Engine

15.2      Market Overview

15.3      Cardiovascular

15.3.1   Market Overview

15.3.2   Market Size & Forecast

15.3.3   Cardiovascular: Geography Segmentation

15.4      Anti-Infectives

15.4.1   Market Overview

15.4.2   Market Size & Forecast

15.4.3   Anti-Infectives: Geography Segmentation

15.5      Oncology

15.5.1   Market Overview

15.5.2   Market Size & Forecast

15.5.3   Oncology: Geography Segmentation

15.6      Pain Management

15.6.1   Market Overview

15.6.2   Market Size & Forecast

15.6.3   Pain Medication: Geography Segmentation

15.7      Behavioral & Mental Health

15.7.1   Market Overview

15.7.2   Market Size & Forecast

15.7.3   Behavioral & Mental Health: Geography Segmentation

15.8      Others

15.8.1   Market Overview

15.8.2   Market Size & Forecast

15.8.3   Others: Geography Segmentation

 

16         End-User

16.1      Market Snapshot & Growth Engine

16.2      Market Overview

16.3      Technology Vendors

16.3.1   Market Overview

16.3.2   Market Size & Forecast

16.3.3   Technology Vendors: Geography Segmentation

16.4      Independent And Specialty Pharmacies

16.4.1   Market Overview

16.4.2   Market Size & Forecast

16.4.3   Independent & Specialty Pharmacies: Geography Segmentation

16.5      Healthcare Facilities

16.5.1   Market Overview

16.5.2   Market Size & Forecast

16.5.3   Healthcare Facilities: Geography Segmentation

16.6      PBMS / PAYORS

16.6.1   Market Overview

16.6.2   Market Size & Forecast

16.6.3   PBM & Payors: Geography Segmentation

 

17         Geography

17.1      Market Snapshot & Growth Engine

17.2      Geographic Overview

 

18         North America

18.1      Market Overview

18.2      Market Size & Forecast

18.2.1   North America: Type Segmentation

18.2.2   North America: Delivery Mode

18.2.3   North America: Modality

18.2.4   North America: Medication Type

18.2.5   North America: End user

18.3      Key Countries

18.3.1   US: Market Size & Forecast

18.3.2   Canada: Market Size & Forecast

 

19         Europe

19.1      Market Overview

19.2      Market Size & Forecast

19.2.1   Europe: Type

19.2.2   Europe: Delivery Mode

19.2.3   Europe: Modality

19.2.4   Europe: Medication Type

19.2.5   Europe: End user

19.3      Key Countries

19.3.1   UK: Market Size & Forecast

19.3.2   Italy: Market Size & Forecast

19.3.3   Spain: Market Size & Forecast

 

20         APAC

20.1      Market Overview

20.2      Market Size & Forecast

20.2.1   APAC: Type

20.2.2   APAC: Delivery Mode

20.2.3   APAC: Modality

20.2.4   APAC: Medication Type

20.2.5   APAC: End user

20.3      Key Countries

20.3.1   China: Market Size & Forecast

20.3.2   Japan: Market Size & Forecast

20.3.3   Australia: Market Size & Forecast

20.3.4   India: Market Size & Forecast

20.3.5   South Korea: Market Size & Forecast

 

21         Latin America

21.1      Market Overview

21.2      Market Size & Forecast

21.2.1   Latin America: Type

21.2.2   Latin America: Delivery Mode

21.2.3   Latin America: Modality

21.2.4   Latin America: Medication Type

21.2.5   Latin America: End user

21.3      Key Countries

21.3.1   Brazil: Market Size & Forecast

21.3.2   Mexico: Market Size & Forecast

21.3.3   Argentina: Market Size & Forecast

 

22         Middle East & Africa

22.1      Market Overview

22.2      Market Size & Forecast

22.2.1   Middle East & Africa: Type

22.2.2   Middle East & Africa: Delivery Mode

22.2.3   Middle East & Africa: Modality

22.2.4   Middle East & Africa: Medication Type

22.2.5   Middle East & Africa: End user

22.3      Key Countries

22.3.1   South Africa: Market Size & Forecast

22.3.2   Saudi Arabia: Market Size & Forecast

22.3.3   Turkey: Market Size & Forecast

 

23         Competitive Landscape

23.1      Competition Overview

23.2      Market Share Analysis

23.2.1   Surescripts in E-prescribing Market

23.2.2   DrFirst in E-prescribing Market

23.2.3   Practice Fusion in E-prescribing Market

23.2.4   InSync Healthcare Solutions in E-prescribing Market

 

24         Key Company Profiles

24.1      Surescripts

24.1.1   Business Overview

24.1.2   Surescripts in E-prescribing Market

24.1.3   Product Offerings

24.1.4   Key Strategies

24.1.5   Key Strengths

24.1.6   Key Opportunities

24.2      DrFirst

24.2.1   Business Overview

24.2.2   DrFirst in E-prescribing Market

24.2.3   Product Offerings

24.2.4   Key Strategies

24.2.5   Key Strengths

24.2.6   Key Opportunities

24.3      Practice Fusion

24.3.1   Business Overview

24.3.2   Practice Fusion in E-prescribing Market

24.3.3   Product Offerings

24.3.4   Key Strategies

24.3.5   Key Strengths

24.3.6   Key Opportunities

24.4      InSync Healthcare Solutions

24.4.1   Business Overview

24.4.2   InSync Healthcare Solutions in E-prescribing Market

24.4.3   Product Offerings

24.4.4   Key Strategies

24.4.5   Key Strengths

24.4.6   Key Opportunities

 

25         Other Prominent Vendors

25.1      eRX NETWORK

25.1.1   Business Overview

25.1.2   Product Offerings

25.2      Henry Schein

25.2.1   Business Overview

25.2.2   Product Offerings

25.3      AdvancedMD

25.3.1   Business Overview

25.3.2   Product Offerings

25.4      MD Toolbox

25.4.1   Business Overview

25.4.2   Product Offerings

25.5      Bravado Health

25.5.1   Business Overview

25.5.2   Product Offerings

25.6      RXNT

25.6.1   Business Overview

25.6.2   Product Offerings

25.7      Daw Systems

25.7.1   Business Overview

25.7.2   Product Offerings

25.8      DoseSpot

25.8.1   Business Overview

25.8.2   Product Offerings

25.9      Chetu

25.9.1   Business Overview

25.9.2   Product Offerings

25.10    Aegis Healthcare

25.10.1 Business Overview

25.10.2 Product Offerings

25.11    SISGAIN

25.11.1 Business Overview

25.11.2 Product Offerings

25.12    Credible

25.12.1 Business Overview

25.12.2 Product Offerings

25.13    Streamline Healthcare Solutions

25.13.1 Business Overview

25.13.2 Product Offerings

25.14    Canada Health Infoway

25.14.1 Business Overview

25.14.2 Product Offerings

25.15    DrChrono

25.15.1 Business Overview

25.15.2 Product Offerings

25.16    BIZMATICS

25.16.1 Business Overview

25.16.2 Product Offerings

 

26         Report Summary

26.1      Key Takeaways

26.2      Strategic Recommendations

 

27         Quantitative Summary

27.1      Market by Type

27.1.1   North America: Type Segmentation

27.1.2   Europe: Type Segmentation

27.1.3   APAC: Type Segmentation

27.1.4   Latin America: Type Segmentation

27.1.5   Middle East & Africa: Type Segmentation

27.2      Market by Delivery Mode

27.2.1   North America: Delivery Mode Segmentation

27.2.2   Europe: Delivery Mode Segmentation

27.2.3   APAC: Delivery Mode Segmentation

27.2.4   Latin America: Delivery Mode Segmentation

27.2.5   Middle East & Africa: Delivery Mode Segmentation

27.3      Market By Modality

27.3.1   North America: Modality Segmentation

27.3.2   Europe: Modality Segmentation

27.3.3   APAC: Modality Segmentation

27.3.4   Latin America: Modality Segmentation

27.3.5   Middle East & Africa: Modality Segmentation

27.4      Market By Medication Type

27.4.1   North America: Medication Type Segmentation

27.4.2   Europe: Medication Type Segmentation

27.4.3   APAC: Medication Type Segmentation

27.4.4   Latin America: Medication Type Segmentation

27.4.5   Middle East & Africa: Medication Type Segmentation

27.5      Market By End User

27.5.1   North America: End user Segmentation

27.5.2   Europe: End user Segmentation

27.5.3   APAC: End user Segmentation

27.5.4   Latin America: End user Segmentation

27.5.5   Middle East & Africa: End user Segmentation

27.7      Market By Geography

27.7.1   Standard E-Prescribing Geography Segmentation

27.7.2   EPCS: Geography Segmentation

27.7.3   Web & Cloud-based: Geography Segmentation

27.7.4   On-Premises & Desktop: Geography Segmentation

27.7.5   Integrated: Geography Segmentation

27.7.6   Standalone: Geography Segmentation

27.7.7   Cardiovascular: Geography Segmentation

27.7.8   Anti-infectives: Geography Segmentation

27.7.9   Oncology: Geography Segmentation

27.7.10 Pain Medication: Geography Segmentation

27.7.11 Behavioral & Mental Health: Geography Segmentation

27.7.12 Others: Geography Segmentation

27.7.13 Technology Vendors: Geography Segmentation

27.7.14 Independent & Specialty Pharmacies: Geography Segmentation

27.7.15 Healthcare Facilities: Geography Segmentation

27.7.16 PBM & Payors: Geography Segmentation

 

28         Appendix

28.1      Abbreviations

             

 

List of Exhibits 

Exhibit 1             Segmentation of Global E-prescribing Market

Exhibit 2             Market Size Calculation Approach 2020

Exhibit 3             Graduated levels of Electronic Prescribing

Exhibit 4             Impact of Development of Indication-based E-Prescribing Systems

Exhibit 5             Impact of Outsourcing E-prescribing Software Development

Exhibit 6             Impact of Advancements in E-Prescribing Solutions

Exhibit 7             Timeline for the development of e-prescribing from EHR

Exhibit 8             Evolution of E-prescribing

Exhibit 9             Impact of Increased demand for EHR services

Exhibit 10           Impact of Government Initiatives & Incentive Programs

Exhibit 11           Impact of Prescription Error Prevention & Clinical Decision Support Automation

Exhibit 12           Impact of Increasing Focus to Reduce & Monitor Controlled Substances

Exhibit 13           Statistics of electronic prescribing of controlled substances

Exhibit 14           Impact of E-Prescribing & E-Formulary Errors

Exhibit 15           Impact of High Cost of Development & Security Concerns

Exhibit 16           Impact of Complex Technology & Software Designing Issues

Exhibit 17           Global E-Prescribing Market 2020–2026 ($ million)

Exhibit 18           Global E-prescribing Market by Geography

Exhibit 19           Global E-prescribing Market by Type

Exhibit 20           Global E-prescribing Market by Delivery Mode

Exhibit 21           Global E-prescribing Market by Modality

Exhibit 22           Global E-prescribing Market by Medication Type

Exhibit 23           Global E-prescribing Market by End user

Exhibit 24           Five Forces Analysis 2020

Exhibit 25           Incremental Growth by Type 2020 & 2026

Exhibit 26           Global E-prescribing Market by Type

Exhibit 27           Rate of E-prescribing by Surescripts

Exhibit 28           Global E-prescribing Market by Type: Incremental Growth

Exhibit 29           Global E-prescribing Market by Type: Absolute Growth

Exhibit 30           Number of E-prescriptions by Surescripts (billion)

Exhibit 31           Global E-prescribing Market by Standard E-prescribing: Incremental & Absolute Growth

Exhibit 32           E-prescribing by Pharmacies and Prescribers (%)

Exhibit 33           Global E-prescribing Market by Standard E-prescribing Segment 2020–2026 ($ million)

Exhibit 34           Incremental Growth by Geography 2020 & 2026

Exhibit 35           Number of E-prescribing for Controlled Substances by Surescripts (million)

Exhibit 36           E-prescribing for Controlled Substances by Pharmacies and Prescribers (%)

Exhibit 37           Global E-prescribing Market by EPCS: Incremental & Absolute Growth

Exhibit 38           Global E-prescribing Market by EPCS 2020–2026 ($ million)

Exhibit 39           Incremental Growth by Geography 2020 & 2026

Exhibit 40           Incremental Growth by Delivery Mode 2020 & 2026

Exhibit 41           Global E-prescribing Market by Delivery Mode

Exhibit 42           Global E-prescribing Market by Delivery Mode: Incremental Growth

Exhibit 43           Global E-prescribing Market by Delivery Mode: Absolute Growth

Exhibit 44           Global E-prescribing Market by Web & Cloud-based: Incremental & Absolute Growth

Exhibit 45           Global E-prescribing Market by Web & Cloud-based 2020–2026 ($ million)

Exhibit 46           Incremental Growth by Geography 2020 & 2026

Exhibit 47           Global E-prescribing Market by On-Premises & Desktop: Incremental & Absolute Growth

Exhibit 48           Global E-prescribing Market by On-Premises & Desktop 2020–2026 ($ million)

Exhibit 49           Incremental Growth by Geography 2020 & 2026

Exhibit 50           Incremental Growth by Modality 2020 & 2026

Exhibit 51           Global E-prescribing Market by Modality

Exhibit 52           Prescribers using standalone and integrated e-prescribing (2012)

Exhibit 53           Global E-prescribing Market by Modality: Incremental Growth

Exhibit 54           Global E-prescribing Market by Modality: Absolute Growth

Exhibit 55           Global E-prescribing Market by Integrated: Incremental & Absolute Growth

Exhibit 56           Global E-prescribing Market by Integrated 2020–2026 ($ million)

Exhibit 57           Incremental Growth by Geography 2020 & 2026

Exhibit 58           Global E-prescribing Market by Standalone: Incremental & Absolute Growth

Exhibit 59           Global E-prescribing Market by Standalone 2020–2026 ($ million)

Exhibit 60           Incremental Growth by Geography 2020 & 2026

Exhibit 61           Incremental Growth by Medication Type 2020 & 2026

Exhibit 62           Global E-prescribing Market by Medication Type

Exhibit 63           E-prescribing various classes of medications (%)

Exhibit 64           Top five specialties using EPCS (2019)

Exhibit 65           Global E-prescribing Market by Medication Type: Incremental Growth

Exhibit 66           Global E-prescribing Market by Cardiovascular: Incremental & Absolute Growth

Exhibit 67           Global E-prescribing Market by Cardiovascular 2020–2026 ($ million)

Exhibit 68           Incremental Growth by Geography 2020 & 2026

Exhibit 69           Global E-prescribing Market by Anti-infectives: Incremental & Absolute Growth

Exhibit 70           Global E-prescribing Market by Anti-infectives 2020–2026 ($ million)

Exhibit 71           Incremental Growth by Geography 2020 & 2026

Exhibit 72           Global E-prescribing Market by Oncology: Incremental & Absolute Growth

Exhibit 73           Global E-prescribing Market by Oncology 2020–2026 ($ million)

Exhibit 74           Incremental Growth by Geography 2020 & 2026

Exhibit 75           E-prescribing of Opioids by Surescripts (million)

Exhibit 76           Top five opioid E-prescription by Surescripts (2019)

Exhibit 77           Global E-prescribing Market by Pain medication: Incremental & Absolute Growth

Exhibit 78           Global E-prescribing Market by Pain medication 2020–2026 ($ million)

Exhibit 79           Incremental Growth by Geography 2020 & 2026

Exhibit 80           Global E-prescribing Market by Behavioral & mental health: Incremental & Absolute Growth

Exhibit 81           Global E-prescribing Market Behavioral & mental health 2020–2026 ($ million)

Exhibit 82           Incremental Growth by Geography 2020 & 2026

Exhibit 83           Global E-prescribing Market by Others: Incremental & Absolute Growth

Exhibit 84           Global E-prescribing Market by Others 2020–2026 ($ million)

Exhibit 85           Incremental Growth by Geography 2020 & 2026

Exhibit 86           Incremental Growth by End-user 2020 & 2026

Exhibit 87           Global E-prescribing Market by End user

Exhibit 88           Global E-prescribing Market by End user: Incremental Growth

Exhibit 89           Global E-prescribing Market by End user: Absolute Growth

Exhibit 90           Global E-prescribing Market by Technology Vendors: Incremental & Absolute Growth

Exhibit 91           Prescribers utilizing EHR and standalone e-prescribing on Surescripts network in 2013 (%)

Exhibit 92           Global E-prescribing Market by Technology Vendors 2020–2026 ($ million)

Exhibit 93           Incremental Growth by Geography 2020 & 2026

Exhibit 94           Global E-prescribing Market by Independent & Specialty Pharmacies: Incremental & Absolute Growth

Exhibit 95           E-prescribing Specialty Drugs as Percentage of Total Drug Spend

Exhibit 96           Global E-prescribing Market by Independent & Specialty Pharmacies Market 2020–2026 ($ million)

Exhibit 97           Incremental Growth by Geography 2020 & 2026

Exhibit 98           Global E-prescribing Market by Healthcare Facilities: Incremental & Absolute Growth

Exhibit 99           Global E-prescribing Market by Healthcare Facilities 2020–2026 ($ million)

Exhibit 100        Incremental Growth by Geography 2020 & 2026

Exhibit 101        Global E-prescribing Market by PBM & Payors: Incremental & Absolute Growth

Exhibit 102        Global E-prescribing Market by PBM & Payors 2020–2026 ($ million)

Exhibit 103        Incremental Growth by Geography 2020 & 2026

Exhibit 104        Incremental Growth by Geography 2020 & 2026

Exhibit 105        Global E-prescribing Market by Geography

Exhibit 106        Global E-prescribing Market by Geography: Incremental Growth

Exhibit 107        Global E-prescribing Market by Geography: Absolute Growth

Exhibit 108        Global E-prescribing Market by Geography: Key Countries ($ million)

Exhibit 109        E-prescribing Market in North America: Key Countries

Exhibit 110        North America E-prescribing Market: Incremental & Absolute Growth Comparison

Exhibit 111        E-prescribing Market in North America 2020–2026 ($ million)

Exhibit 112        Incremental Growth by Type 2020 & 2026

Exhibit 113        Incremental Growth by Delivery Mode 2020 & 2026

Exhibit 114        Incremental Growth by Modality 2020 & 2026

Exhibit 115        Incremental Growth by Medication Type 2020 & 2026

Exhibit 116        Incremental Growth by End user 2020 & 2026

Exhibit 117        Incremental Growth in North America 2020 & 2026

Exhibit 118        EHR adoption rate in the US (%)

Exhibit 119        E-prescribing Market in the US 2020–2026 ($ million)

Exhibit 120        E-prescribing Market in Canada 2020–2026 ($ million)

Exhibit 121        E-prescribing Market in Europe: Key Countries

Exhibit 122        Growth of e-prescribing in primary care in Europe (%)

Exhibit 123        Europe E-prescribing Market: Incremental & Absolute Growth

Exhibit 124        E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 125        Incremental Growth by Type 2020 & 2026

Exhibit 126        Incremental Growth by Delivery Mode 2020 & 2026

Exhibit 127        Incremental Growth by Modality 2020 & 2026

Exhibit 128        Incremental Growth by Medication Type 2020 & 2026

Exhibit 129        Incremental Growth by End user 2020 & 2026

Exhibit 130        Incremental Growth in Europe 2020 & 2026

Exhibit 131        E-prescribing Market in UK 2020–2026 ($ million)

Exhibit 132        E-prescribing Market in Italy 2020–2026 ($ million)

Exhibit 133        E-prescribing Market in Spain 2020–2026 ($ million)

Exhibit 134        E-prescribing Market in APAC: Key Countries

Exhibit 135        Annual prevalence for the use of opioids in Asia in 2017 (%)

Exhibit 136        APAC E-prescribing Market: Incremental & Absolute Growth

Exhibit 137        E-prescribing Market in APAC 2020–2026 ($ million)

Exhibit 138        Incremental Growth by Type 2020 & 2026

Exhibit 139        Incremental Growth by Delivery Mode 2020 & 2026

Exhibit 140        Incremental Growth by Modality 2020 & 2026

Exhibit 141        Incremental Growth by Medication Type 2020 & 2026

Exhibit 142        Incremental Growth by End user 2020 & 2026

Exhibit 143        Incremental Growth in APAC 2020 & 2026

Exhibit 144        E-prescribing Market in China 2020–2026 ($ million)

Exhibit 145        E-prescribing Market in Japan 2020–2026 ($ million)

Exhibit 146        E-prescribing Market in Australia 2020–2026 ($ million)

Exhibit 147        E-prescribing Market in India 2020–2026 ($ million)

Exhibit 148        E-prescribing Market in South Korea 2020–2026 ($ million)

Exhibit 149        E-prescribing Market in Latin America: Key Countries

Exhibit 150        Latin America E-prescribing Market: Incremental & Absolute Growth

Exhibit 151        E-prescribing Market in Latin America 2020–2026 ($ million)

Exhibit 152        Incremental Growth by Type 2020 & 2026

Exhibit 153        Incremental Growth by Delivery Mode 2020 & 2026

Exhibit 154        Incremental Growth by Modality 2020 & 2026

Exhibit 155        Incremental Growth by Medication Type 2020 & 2026

Exhibit 156        Incremental Growth by End user 2020 & 2026

Exhibit 157        Incremental Growth in Latin America 2020 & 2026

Exhibit 158        E-prescribing Market in Brazil 2020–2026 ($ million)

Exhibit 159        E-prescribing Market in Mexico 2020–2026 ($ million)

Exhibit 160        E-prescribing Market in Argentina 2020–2026 ($ million)

Exhibit 161        E-prescribing Market in Middle East & Africa: Key Countries

Exhibit 162        Middle East & Africa E-prescribing Market: Incremental & Absolute Growth

Exhibit 163        E-prescribing Market in Middle East & Africa 2020–2026 ($ million)

Exhibit 164        Incremental Growth by Type 2020 & 2026

Exhibit 165        Incremental Growth by Delivery Mode 2020 & 2026

Exhibit 166        Incremental Growth by Modality 2020 & 2026

Exhibit 167        Incremental Growth by Medication Type 2020 & 2026

Exhibit 168        Incremental Growth by End-user 2020 & 2026

Exhibit 169        Incremental Growth in Middle East & Africa 2020 & 2026

Exhibit 170        E-prescribing Market in South Africa 2020–2026 ($ million)

Exhibit 171        E-prescribing Market in Saudi Arabia 2020–2026 ($ million)

Exhibit 172        E-prescribing Market in Turkey 2020–2026 ($ million)

Exhibit 173        Global e-Prescribing Market: Vendors Market Shares 2020

             

             

List of Tables    

Table 1               Key Caveats

Table 2               Currency Conversion 2013−2020

Table 3               Consequences of E-prescribing errors

Table 4               Cost associated with basic e-prescribing and EPCS in most widely used EHRs

Table 5               Pros & Cons for Standalone & Integrated E-prescribing solutions

Table 6               North America E-prescribing Market by Type 2020−2026 ($ million)

Table 7               North America E-prescribing Market by Type 2020−2026 (%)

Table 8               North America E-prescribing Market by Delivery Mode 2020−2026 ($ million)

Table 9               North America E-prescribing Market by Delivery Mode 2020−2026 (%)

Table 10             North America E-prescribing Market by Modality 2020−2026 ($ million)

Table 11             North America E-prescribing Market by Modality 2020−2026 (%)

Table 12             North America E-prescribing Market by Medication Type 2020−2026 ($ million)

Table 13             North America E-prescribing Market by Medication Type 2020−2026 (%)

Table 14             North America E-prescribing Market by End user 2020−2026 ($ million)

Table 15             North America E-prescribing Market by End user 2020−2026 (%)

Table 16             Europe E-prescribing Market by Type 2020−2026 ($ million)

Table 17             Europe E-prescribing Market by Type 2020−2026 (%)

Table 18             Europe E-prescribing Market by Delivery Mode 2020−2026 ($ million)

Table 19             Europe E-prescribing Market by Delivery Mode 2020−2026 (%)

Table 20             Europe E-prescribing Market by Modality 2020−2026 ($ million)

Table 21             Europe E-prescribing Market by Modality 2020−2026 (%)

Table 22             Europe E-prescribing Market by Medication Type 2020−2026 ($ million)

Table 23             Europe E-prescribing Market by Medication Type 2020−2026 (%)

Table 24             Europe E-prescribing Market by End user 2020−2026 ($ million)

Table 25             Europe E-prescribing Market by End user 2020−2026 (%)

Table 26             APAC E-prescribing Market by Type 2020−2026 ($ million)

Table 27             APAC E-prescribing Market by Type 2020−2026 (%)

Table 28             APAC E-prescribing Market by Delivery Mode 2020−2026 ($ million)

Table 29             APAC E-prescribing Market by Delivery Mode 2020−2026 (%)

Table 30             APAC E-prescribing Market by Modality 2020−2026 ($ million)

Table 31             APAC E-prescribing Market by Modality 2020−2026 (%)

Table 32             APAC E-prescribing Market by Medication Type 2020−2026 ($ million)

Table 33             APAC E-prescribing Market by Medication Type 2020−2026 (%)

Table 34             APAC E-prescribing Market by End user 2020−2026 ($ million)

Table 35             APAC E-prescribing Market by End user 2020−2026 (%)

Table 36             Latin America E-prescribing Market by Type 2020−2026 ($ million)

Table 37             Latin America E-prescribing Market by Type 2020−2026 (%)

Table 38             Latin America E-prescribing Market by Delivery Mode 2020−2026 ($ million)

Table 39             Latin America E-prescribing Market by Delivery Mode 2020−2026 (%)

Table 40             Latin America E-prescribing Market by Modality 2020−2026 ($ million)

Table 41             Latin America E-prescribing Market by Modality 2020−2026 (%)

Table 42             Latin America E-prescribing Market by Medication Type 2020−2026 ($ million)

Table 43             Latin America E-prescribing Market by Medication Type 2020−2026 (%)

Table 44             Latin America E-prescribing Market by End user 2020−2026 ($ million)

Table 45             Latin America E-prescribing Market by End user 2020−2026 (%)

Table 46             Middle East & Africa E-prescribing Market by Type 2020−2026 ($ million)

Table 47             Middle East & Africa E-prescribing Market by Type 2020−2026 (%)

Table 48             Middle East & Africa E-prescribing Market by Delivery Mode 2020−2026 ($ million)

Table 49             Middle East & Africa E-prescribing Market by Delivery Mode 2020−2026 (%)

Table 50             Middle East & Africa E-prescribing Market by Modality 2020−2026 ($ million)

Table 51             Middle East & Africa E-prescribing Market by Modality 2020−2026 (%)

Table 52             Middle East & Africa E-prescribing Market by Medication Type 2020−2026 ($ million)

Table 53             Middle East & Africa E-prescribing Market by Medication Type 2020−2026 (%)

Table 54             Middle East & Africa E-prescribing Market by End user 2020−2026 ($ million)

Table 55             Middle East & Africa E-prescribing Market by End user 2020−2026 (%)

Table 56             Surescripts: Major Product Offerings

Table 57             DrFirst: Major Product Offerings

Table 58             Practice Fusion: Major Product Offerings

Table 59             Company 1: Major Product Offerings

Table 60             eRx Network: Major Product Offerings

Table 61             Henry Schein: Major Product Offerings

Table 62             AdvancedMD: Major Product Offerings

Table 63             MD Toolbox: Major Product Offerings

Table 64             Bravado Health: Major Product Offerings

Table 65             RXNT: Major Product Offerings

Table 66             Daw Systems: Major Product Offerings

Table 67             DoseSpot: Major Product Offerings

Table 68             Chetu Inc: Major Product Offerings

Table 69             Aegis Healthcare: Major Product Offerings

Table 70             SISGAIN: Major Product Offerings

Table 71             Credible: Major Product Offerings

Table 72             Streamline Healthcare Solutions: Major Product Offerings

Table 73             Canada Health Infoway: Major Product Offerings

Table 74             DrChrono: Major Product Offerings

Table 75             Bizmatics: Major Product Offerings

Table 76             Global E-prescribing Market by Type 2020−2026 ($ million)

Table 77             Global E-prescribing Market by Type 2020−2026 (%)

Table 78             North America E-prescribing Market by Type 2020−2026 ($ million)

Table 79             North America E-prescribing Market by Type 2020−2026 (%)

Table 80             Europe E-prescribing Market by Type 2020−2026 ($ million)

Table 81             Europe E-prescribing Market by Type 2020−2026 (%)

Table 82             APAC E-prescribing Market by Type 2020−2026 ($ million)

Table 83             APAC E-prescribing Market by Type 2020−2026 (%)

Table 84             Latin America E-prescribing Market by Type 2020−2026 ($ million)

Table 85             Latin America E-prescribing Market by Type 2020−2026 (%)

Table 86             Middle East & Africa E-prescribing Market by Type 2020−2026 ($ million)

Table 87             Middle East & Africa E-prescribing Market by Type 2020−2026 (%)

Table 88             Global E-prescribing Market by Delivery Mode 2020−2026 ($ million)

Table 89             Global E-prescribing Market by Delivery Mode 2020−2026 (%)

Table 90             North America E-prescribing Market by Delivery Mode 2020−2026 ($ million)

Table 91             North America E-prescribing Market by Delivery Mode 2020−2026 (%)

Table 92             Europe E-prescribing Market by Delivery Mode 2020−2026 ($ million)

Table 93             Europe E-prescribing Market by Delivery Mode 2020−2026 (%)

Table 94             APAC E-prescribing Market by Delivery Mode 2020−2026 ($ million)

Table 95             APAC E-prescribing Market by Delivery Mode 2020−2026 (%)

Table 96             Latin America E-prescribing Market by Delivery Mode 2020−2026 ($ million)

Table 97             Latin America E-prescribing Market by Delivery Mode 2020−2026 (%)

Table 98             Middle East & Africa E-prescribing Market by Delivery Mode 2020−2026 ($ million)

Table 99             Middle East & Africa E-prescribing Market by Delivery Mode 2020−2026 (%)

Table 100           Global E-prescribing Market by Modality 2020−2026 ($ million)

Table 101           Global E-prescribing Market by Modality 2020−2026 (%)

Table 102           North America E-prescribing Market by Modality 2020−2026 ($ million)

Table 103           North America E-prescribing Market by Modality 2020−2026 (%)

Table 104           Europe E-prescribing Market by Modality 2020−2026 ($ million)

Table 105           Europe E-prescribing Market by Modality 2020−2026 (%)

Table 106           APAC E-prescribing Market by Modality 2020−2026 ($ million)

Table 107           APAC E-prescribing Market by Modality 2020−2026 (%)

Table 108           Latin America E-prescribing Market by Modality 2020−2026 ($ million)

Table 109           Latin America E-prescribing Market by Modality 2020−2026 (%)

Table 110           Middle East & Africa E-prescribing Market by Modality 2020−2026 ($ million)

Table 111           Middle East & Africa E-prescribing Market by Modality 2020−2026 (%)

Table 112           Global E-prescribing Market by Medication Type 2020−2026 ($ million)

Table 113           Global E-prescribing Market by Medication Type 2020−2026 (%)

Table 114           North America E-prescribing Market by Medication Type 2020−2026 ($ million)

Table 115           North America E-prescribing Market by Medication Type 2020−2026 (%)

Table 116           Europe E-prescribing Market by Medication Type 2020−2026 ($ million)

Table 117           Europe E-prescribing Market by Medication Type 2020−2026 (%)

Table 118           APAC E-prescribing Market by Medication Type 2020−2026 ($ million)

Table 119           APAC E-prescribing Market by Medication Type 2020−2026 (%)

Table 120           Latin America E-prescribing Market by Medication Type 2020−2026 ($ million)

Table 121           Latin America E-prescribing Market by Medication Type 2020−2026 (%)

Table 122           Middle East & Africa E-prescribing Market by Medication Type 2020−2026 ($ million)

Table 123           Middle East & Africa E-prescribing Market by Medication Type 2020−2026 (%)

Table 124           Global E-prescribing Market by End user 2020−2026 ($ million)

Table 125           Global E-prescribing Market by End user 2020−2026 (%)

Table 126           North America E-prescribing Market by End user 2020−2026 ($ million)

Table 127           North America E-prescribing Market by End user 2020−2026 (%)

Table 128           Europe E-prescribing Market by End user 2020−2026 ($ million)

Table 129           Europe E-prescribing Market by End user 2020−2026 (%)

Table 130           APAC E-prescribing Market by End user 2020−2026 ($ million)

Table 131           APAC E-prescribing Market by End user 2020−2026 (%)

Table 132           Latin America E-prescribing Market by End user 2020−2026 ($ million)

Table 133           Latin America E-prescribing Market by End user 2020−2026 (%)

Table 134           Middle East & Africa E-prescribing Market by End user 2020−2026 ($ million)

Table 135           Middle East & Africa E-prescribing Market by End user 2020−2026 (%)

Table 136           Global E-prescribing Market by Geography 2020−2026 ($ million)

Table 137           Global E-prescribing Market by Geography 2020−2026 (%)

Table 138           Standard E-prescribing in E-prescribing Market by Geography 2020−2026 ($ million)

Table 139           Standard E-prescribing in E-prescribing Market by Geography 2020−2026 (%)

Table 140           EPCS in E-prescribing Market by Geography 2020−2026 ($ million)

Table 141           EPCS in E-prescribing Market by Geography 2020−2026 (%)

Table 142           Web & Cloud-based in E-prescribing Market by Geography 2020−2026 ($ million)

Table 143           Web & Cloud-based in E-prescribing Market by Geography 2020−2026 (%)

Table 144           On-Premises & Desktop in E-prescribing Market by Geography 2020−2026 ($ million)

Table 145           On-Premises & Desktop in E-prescribing Market by Geography 2020−2026 (%)

Table 146           Integrated in E-prescribing Market by Geography 2020−2026 ($ million)

Table 147           Integrated in E-prescribing Market by Geography 2020−2026 (%)

Table 148           Standalone in E-prescribing Market by Geography 2020−2026 ($ million)

Table 149           Standalone in E-prescribing Market by Geography 2020−2026 (%)

Table 150           Cardiovascular in E-prescribing Market by Geography 2020−2026 ($ million)

Table 151           Cardiovascular in E-prescribing Market by Geography 2020−2026 (%)

Table 152           Anti-infectives in E-prescribing Market by Geography 2020−2026 ($ million)

Table 153           Anti-infectives in E-prescribing Market by Geography 2020−2026 (%)

Table 154           Oncology in E-prescribing Market by Geography 2020−2026 ($ million)

Table 155           Oncology in E-prescribing Market by Geography 2020−2026 (%)

Table 156           Pain Medication in E-prescribing Market by Geography 2020−2026 ($ million)

Table 157           Pain Medication in E-prescribing Market by Geography 2020−2026 (%)

Table 158           Behavioral & Mental Health in E-prescribing Market by Geography 2020−2026 ($ million)

Table 159           Behavioral & Mental Health in E-prescribing Market by Geography 2020−2026 (%)

Table 160           Others in E-prescribing Market by Geography 2020−2026 ($ million)

Table 161           Others in E-prescribing Market by Geography 2020−2026 (%)

Table 162           Technology Vendors in E-prescribing Market by Geography 2020−2026 ($ million)

Table 163           Technology Vendors in E-prescribing Market by Geography 2020−2026 (%)

Table 164           Independent & Specialty Pharmacies in E-prescribing Market by Geography 2020−2026 ($ million)

Table 165           Independent & Specialty Pharmacies in E-prescribing Market by Geography 2020−2026 (%)

Table 166           Healthcare Facilities in E-prescribing Market by Geography 2020−2026 ($ million)

Table 167           Healthcare Facilities in E-prescribing Market by Geography 2020−2026 (%)

Table 168           PBM & Payors in E-prescribing Market by Geography 2020−2026 ($ million)

Table 169           PBM & Payors in E-prescribing Market by Geography 2020−2026 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3995.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4500.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5500.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date